Pharmacotherapeutic strategies for pediatric bipolar disorder

Expert Opinion on Pharmacotherapy

Volumn 8, Issue 12, 2007, Pages 1801-1819

  Madaan, Vishal ^a   Chang, Kiki D ^b  

^a CREIGHTON UNIVERSITY   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Atypical antipsychotic; Mood stabilizer; Pediatric bipolar disorder

Indexed keywords

AMPHETAMINE; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CENTRAL STIMULANT AGENT; CLOZAPINE; FATTY ACID; GABAPENTIN; LAMOTRIGINE; LITHIUM; METHYLPHENIDATE; MINERAL; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; OXCARBAZEPINE; PLACEBO; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; VALPROATE SEMISODIUM; VITAMIN; ZIPRASIDONE;

ABDOMINAL DISEASE; ACNE; AGE DISTRIBUTION; AGRANULOCYTOSIS; APLASTIC ANEMIA; ATAXIA; ATRIOVENTRICULAR BLOCK; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; BIPOLAR DISORDER; BLOOD DYSCRASIA; BLOOD SAMPLING; BLURRED VISION; CHILD PSYCHIATRY; CHRONIC DISEASE; CLINICAL PRACTICE; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; COMBINATION CHEMOTHERAPY; COMORBIDITY; CONSENSUS DEVELOPMENT; DIABETES INSIPIDUS; DIARRHEA; DIET SUPPLEMENTATION; DIPLOPIA; DISEASE CLASSIFICATION; DISEASE COURSE; DIZZINESS; DRUG ABSORPTION; DRUG APPROVAL; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG MONITORING; DRUG POTENTIATION; DRUG RESPONSE; DRUG SAFETY; DRUG SUBSTITUTION; DRUG USE; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; EMPIRICAL RESEARCH; EXTRAPYRAMIDAL SYMPTOM; FAMILY HISTORY; FAMILY THERAPY; FATIGUE; HAIR LOSS; HEART ARRHYTHMIA; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPONATREMIA; HYPOTENSION; HYPOTHYROIDISM; LEUKOPENIA; LIVER TOXICITY; LOW DRUG DOSE; METABOLIC DISORDER; METABOLIC SYNDROME X; MONOTHERAPY; MYOCARDITIS; NAUSEA; NEURAL TUBE DEFECT; NEUROTOXICITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OPTIMAL DRUG DOSE; ORTHOSTATIC HYPOTENSION; OVARY POLYCYSTIC DISEASE; PANCREATITIS; PATIENT COMPLIANCE; POLYDIPSIA; POLYURIA; PRACTICE GUIDELINE; PRESCRIPTION; PROLACTIN BLOOD LEVEL; PSYCHOEDUCATION; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; REVIEW; SALIVATION; SEDATION; SEIZURE; SIDE EFFECT; SOMNOLENCE; STEVENS JOHNSON SYNDROME; THROMBOCYTE COUNT; TOXIC EPIDERMAL NECROLYSIS; TREMOR; WEIGHT GAIN; XEROSTOMIA;

ADOLESCENT; ANTICONVULSANTS; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CARBAMAZEPINE; CHILD; DRUG THERAPY, COMBINATION; HUMANS; LITHIUM; VALPROIC ACID;

EID: 34548293164     PISSN: 14656566     EISSN: None     Source Type: Journal    
DOI: 10.1517/14656566.8.12.1801     Document Type: Review

References (108)

1. GELLER B, LUBY J: Child and adolescent bipolar disorder: a review of the past 10 years. J. Am. Acad. Child Adolesc. Psychiatry (1997) 36(9):1168-1176.
2. MCLELLAN J: Commentary: treatment guidelines for child and adolescent bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry (2005) 44(3):236-239.
3. GELLER B, BOLHOFNER K, CRANEY J et al.: Psychosocial functioning in a prepubertal and early adolescent bipolar disorder phenotype. J. Am. Acad. Child Adolesc. Psychiatry (2000) 39(12):1543-1548.
4. KOWATCH RA, DELBELLO MP: Pediatric bipolar disorder: emerging diagnostic and treatment approaches. Child Adolesc. Psychiatr Clin. N. Am. (2006) 15(1):73-108.
5. SIMKIN DR: Adolescent substance use disorders and comorbidity. Pediatr. Clin. North Am. (2002) 49(2):463-477.
6. GOLDSTEIN TR, BIRMAHER B, AXELSON D et al.: History of suicide attempts in pediatric bipolar disorder: factors associated with increased risk. Bipolar Disord. (2005) 7(6):525-535.
7. LEWINSOHN PM, KLEIN DN, SEELEY JR: Bipolar disorders in a community sample of older adolescents: prevalence, phenomenology, comorbidity, and course. J. Am. Acad. Child Adolesc. Psychiatry (1995) 34(4):454-463.
8. YOUNGSTROM EA, DAUX J: Evidence-based assessment of pediatric bipolar disorder, Part I: base rate and family history. J. Am. Acad. Child Adolesc. Psychiatry (2005) 44(7):712-717.
9. KOWATCH RA, DELBELLO MP: Pharmacotherapy of children and adolescents with bipolar disorder. Psychiatr. Clin. North Am. (2005) 28(2):385-397.
10. MARCHAND WR, WIRTH L, SIMON C: Delayed diagnosis of pediatric bipolar disorder in a community mental health setting. J. Psychiatr. Pract. (2006) 12(2):128-133.
11. GELLER B, CRANEY JL, BOLHOFNER K, DELBELLO MP, WILLIAMS M, ZIMERMAN B: One-year recovery and relapse rates of children with a prepubertal and early adolescent bipolar disorder phenotype. Am. J. Psychiatry (2001) 158(2):303-305.
12. GELLER B, TILLMAN R, CRANEY JL, BOLHOFNER K: Four-year prospective outcome and natural history of mania in children with a prepubertal and early adolescent bipolar disorder phenotype. Arch. Gen. Psychiatry (2004) 61(5):459-467.
13. AMERICAN PSYCHIATRIC ASSOCIATION: Diagnostic and Statistical Manual of Mental Disorder, 4th Edition (DSM-IV). American Psychiatric Association, Washington, DC. (1994).
14. WOZNIAK J, BIEDERMAN J, KWON A et al.: How cardinal are cardinal symptoms in pediatric bipolar disorder? An examination of clinical correlates. Biol. Psychiatry (2005) 58(7):583-588.
15. DILSAVER SC, BENAZZI F, AKISKAL HS: Mixed states: the most common outpatient presentation of bipolar depressed adolescents? Psychopathology (2005) 38(5):268-272.
16. BIRMAHER B, AXELSON D, STROBER M et al.: Clinical course of children and adolescents with bipolar spectrum disorders. Arch. Gen. Psychiatry (2006) 63:175-183.
17. AXELSON D, BIRMAHER B, STROBER M et al.: Phenomenology of children and adolescents with bipolar spectrum disorders. Arch. Gen. Psychiatry (2006) 63(10):1139-1148.
18. LEIBENLUFT E: Flying almost blind. Am. J. Psychiatry (2006) 163(7):1129-1131.
19. LEIBENLUFT E, CHARNEY DS, TOWBIN KE, BHANGOO RK, PINE DS: Defining clinical phenotypes of juvenile mania. Am. J. Psychiatry (2003) 160:430-437.
20. PUIG-ANTICH J, CHAMBERS W: Schedule for Affective Disorders and Schizophrenia for School-Age Children (KIDDIE-SADS). New York State Psychiatric Institute, Biometrics Research, New York (1978).
21. GELLER B, WARNER K, WILLIAMS M et al.: Prepubertal and young adolescent bipolarity versus ADHD: assessment and validity using the WASH-U-KSADS, CBCL and TRF. J. Affect. Disord. (1998) 51(2):93-100.
22. SHAFFER D, FISHER P, LUCAS CP et al.: NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common dlagnoses. J. Am. Acad. Child Adolesc. Psychiatry (2000) 39(1):28-38.
23. WELLER E, WELLER R, FRISTAD M et al.: Children's Interview for Psychiatric Syndromes (ChIPS). Washington (DC): American Psychiatric Press (1999).
24. HIRSCHFIELD RM, HOLZER C, CALABRESE JR et al.: Validity of the mood disorder questionnaire: a general population study. Am. J. Psychiatry (2003) 160(1):178-218.
25. YOUNG RC, BIGGS JT, ZIEGLER VE et al.: A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry (1978) 133:429-435.
26. PAPOLOS D, HENNEN J, COCKERHAM MS, THODE HC Jr, YOUNGSTROM EA: The child bipolar questionnaire: a dimensional approach to screening for pediatric bipolar disorder. J. Affect. Disord. (2006) 95(1-3):149-158.
27. SPEARING MK, POST RM, LEVERICH GS, BRANDT D, NOLEN W: Modification of the Clinical Global Impressions (CGI) scale for use with bipolar illness (BP): the CGI: BP. Psychiatry Res. (1997) 73:159-171.
28. GRACIOUS BL, YOUNGSTROM EA, FINDLING RL, CALABRESE JR: Discriminative validity of a parent version of the Young Mania Rating Scale. J. Am. Acad. Child Adolesc. Psychiatry (2002) 41(11):1350-1359.
29. DEPUE RA: General Behavior Inventory (manud) (Assessment Manual). University of Minnesota, Minneapolis, MN. (1987).
30. PAVULURI M, HENRY D, DEVINENI B, CARBRAY J, BIRMAHER B: Child Mania Rating Scale: development, reliability, and validity. J. Am. Acad. Child Adolesc. Psychiatry (2O06) 45:550-560.
31. PAVULURI MN, BIRMAHER B, NAYLOR MW: Pediatric bipolar disorder: a review of the past 10 years. J. Am. Acad. Child Adolesc. Psychiatry (2005) 44(9):846-871.
32. GELLER B, ZIMERMAN B, WILLIAMS M et al.: Diagnostic charactetistics of 93 cases of prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder. J. Child Adolesc. Psychopharmacol. (2000) 10:157-164.
33. GELLER B, COOPER TB, SUN K et al.: Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J. Am. Acad. Child Adolesc. Psychiatry (1998) 37(2):171-178.
34. KAFANTARIS V, COLETTI DJ, DICKER R, PADULA G, KANE JM: Lithium treatment of acute mania in adolescents: a large open trial. J. Am. Acad. Child Adolesc. Psychiatry (2003) 42:1038-1045.
35. STROBER M, MORRELL W, LAMPERT C et al.: Relapse following discontinuation of lithium maintenance therapy in adolescents with bipolar I illness. a naturalistic study. Am. J. Psychiatry (1990) 147(4):457-461.
36. BELMAKER RH, BERSUDSKY Y, AGAM G et al.: How does lithium work on manic depression? Clinical and psychological correlates of the inositol theory. Annu. Rev. Med. (1996) 47:47-56.
37. MANJI HK, CHEN G: PKC, MAP kinases and the bcl-2 family of proteins as long term targets for mood stabilizers. Mol. Psychiatry (2002) 7(Suppl. 1):S46-S56.
38. HASHIMOTO R, TAKEI N, SHIMAZU K et al.: Lithium induces brain-derived neurotrophic factor and activates TrkB in rodent cortical neurons: an essential step for neuroprotection against glutamate excitotoxicity. Neuropharmacology (2002) 43(7):1173-1179.
39. WELLER EB, WELLER RA, FRISTAD MA: Lithium dosage guide for prepubertal children: a preliminary report. J. Am. Acad. Child Psychiatry (1986) 25(1):92-95.
40. MOORE CM, DEMOPULOS CM, HENRY ME et al.: Brain-to-serum lithium ratio and age: an in vivo magnetic resonance spectroscopy study. Am. J. Psychiatry (2002) 159(7):1240-1242.
41. CAMPBELL M, SILVA RR, KAFANTARIS V et al.: Predictors of side effects associated with lithium administration in children. Psychopharmacol. Bull. (1991 ) 27(3):373-380.
42. HAGINO OR, WELLER EB, WELLER RA et al.: Untoward effects of lithium treatment in children aged four through six years. J. Am. Acad. Child Adolesc. Psychiatry (1995) 34(12):1584-1590.
43. DANIELYAN A, KOWATCH RA: Management options for bipolar disorder in children and adolescents. Pediatr. Drugs (2005) 7(5):277-294.
44. FINDLING RI., MCNAMARA NK, GRACIOUS BL et al.: Combination lithium and divalproex sodium in pediatric bipolarity. J. Am. Acad. Child Adolesc. Psychiatry (2003) 42(8):895-901.
45. GROF P, DUFFY A, CAVAZZONI P et al.: Is response to prophylactic lithium a familial trait? J. Clin. Psychiatry (2002) 63(10):942-947.
46. KUTCHER SP, MARTON R KORENBLUM M: Adolescent bipolar illness and personality disorder. J. Am. Acad. Child Adolesc. Psychiatry (1990) 29(3):355-358.
47. CHEN G, MANJI HK, WRIGHT CB et al.: Effects of valproic acid on β-adrenergic receptors, G-proteins, and adenylyl cyclase in rat C6 glioma cells. Neuropsychopharmacology (1996) 15(3):271-280.
48. CLOYD JC, FISCHER JH, KRIEL RL et al.: Valproic acid pharmacokinetics in children: IV. Effects of age and antiepileptic drugs on protein binding and intrinsic clearance. Clin. Pharmacol. Ther. (1993) 53(1):22-29.
49. BOWDEN CL, JANICAK PG, ORSULAK P et al.: Relation of serum valproic acid concentration to reaponse in mania. Am. J. Psychiatr. (1996) 153(6):765-770.
50. ISOJARVI JI, LAATIKAINEN TI, KNIP M et al.: Obesity and endocrine disorders in women taking valproic acid for epilepsy. Ann. Neurol. (1996) 39(5):579-584.
51. WAGNER KD, WELLER EB, CARLSON GA et al.: An open-label trial of divalproex in children and adolescents with bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry (2002) 41(10):1224-1230.
52. SCHEFFER RE, KOWATCH RA, CARMODY T, RUSH AJ: Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am. J. Psychiatry (2005) 162(1):58-64.
53. HENRY CA, ZAMVIL LS, LAM C, ROSENQUIST KJ, GHAEMI SN: Long-term outcome with divalproex in children and adolescents with bipolar disorder. J. Child Adolesc. Psychopharmacol. (2003) 13(4):523-529.
54. CHANG KD, DIENES K, BLASEY C, ADLEMAN N, KETTER T, STEINER H: Divalproex monotherapy in the treatment of bipolar offspring with mood and behavioral disorders and at least mild affective symptoms. J. Clin. Psychiatry (2003) 64(8):936-942.
55. MANJI HK, MOORE GJ, CHEN G: Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic-depressive illness. Biol. Psychiatry (2000) 441(8):740-754.
56. MANJI HK, CHEN G, HSIAO JK et al.: Regulation of signal transduction pathways by mood-stabilizing agents: implications for the delayed onset of therapeutic efficacy. J. Clin. Psychiatry (1996) 57(Suppl. 13):34-46.
57. CHANG KD, SIMEONOVA D: Mood stabilizers: use in pediatric psychopharmacology. In: Handbook of Mental Health Interventions in Children and Adolescents: An Integrated Developmental Apprioch. Steiner H, Chang K, Lock J, Wilson J (Eds), Jossey-Bass, New York (2004):363-412.
58. REIMERS A, SKOGVOLL E, SUND JK, SPIGSET O: Drug interactions between lamotrigine and psychoactive drugs: evidence from a therapeutic drug monitoring service. J. Clin.Psychopharmacol. (2005) 25(4):342-348.
59. BOURGEOIS BF: Pharmacokinetic: properties of current antiepileptic drugs: what improvements are needed? Neurology (2000) 55(11 Suppl. 3):S11-S16.
60. WOOLSTON JL: Case study: carbamazepine treatment of juvenile-onset bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry (1999) 38(3):335-338.
61. HSU LK: Lithium-resistant adolescent mania. J. Am. Acad. Child Psychiatry. (1986) 25:280-283.
62. KOWATCH RA, SUPPES T, CARMODY TJ et al.: Effect size of lithium, divalproex sodium and carbamazepine in children and adolescents with bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry (2000) 39(6):713-720.
63. TEITELBAUM M: Oxcarbazepine in bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry (2001) 40:993-994.
64. MACMILLAN CM, KORNDORFER SR, RAO S, FLEISHER CA, MEZZACAPPA E, GONZALEZ-HEYDRICH J: A comparison of divalproex and oxcarbazepine in aggressive youth with bipolar disorder. J. Psychiatr. Pract. (2006) 12(4):214-222.
65. WAGNER KD, KOWATCH RA, EMSLIE GJ et al.: A double-blind, randomized, placebo-controlled trial of oxcarbazepine in the treatment of bipolar disorder in children and adolescents. Am. J. Psychiatry (2006) 163:1179-1786. oxcarbazepine in PBD.
66. GUBERMAN AH, BESAG FM, BRODIE MJ et al.: Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia (1999) 40:985-991.
67. MESSENHEIMER J: Efficacy and safety of lamotrigine in pediatric patients. J. Child Neurol. (2002) 17(Suppl. 2):2S34-2S42.
68. GOLDSMITH DR, WAGSTAFF AJ, IBBOTSON T, PERRY CM: Lamotrigine: a review of its use in bipolar disorder. Drugs (2003) 63(19):2029-2050.
69. CHANG K, SAXENA K, HOWE M: An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression. J. Am. Acad. Child Adolesc. Psychiatry (2006) 45(3):298-304.
70. MCELROY SL, KECK PE Jr: Pharmacologic agents for the treatment of acute bipolar mania. Biol. Psychiatry (2000) 48(6):539-557.
71. PANDE AC, POLLACK MH, CROCKATT J et al.: Placebo-controlled study of gabapentin treatment of panic disorder. J. Clin. Psychopharmacol. (2000) 20:467-471.
72. PANDE AC, DAVIDSON JR, JEFFERSON JW et al.: Treatment of social phobia with gabapentin: a placebo-controlled study. J. Clin. Psychopharmacol. (1999) 19:341-348.
73. DELBELLO MP, KOWATCH RA, WARNER J et al.: Adjunctive topiramate treatment for pediatric bipolar disorder: a retrospective chart review. J. Child Adolesc. Psychopharmacol. (2002) 12(4):323-330.
74. DELBELLO MP, FINDLING RL, KUSHNER S et al.: A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry (2005) 44(6):539-547.
75. DELBELLO MP, SCHWIERS ML, ROSENBERG HL et al.: A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J. Am. Acad. Child Adolesc. Psychiatry (2002) 41(10):1216-1223.
76. DELBELLO MP, KOWATCH RA, ADLER CM et al.: A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania. J. Am. Acad. Child Adolesc. Psychiatry (2006) 45(3):305-313.
77. SOUTULLO CA, SORTER MT, FOSTER KD, MCELROY SL, KECK PE: Olanzapine in the treatment of adolescent acute mania: a report of seven cases. J. Affect. Disord. (1999) 53(3):279-283.
78. FRAZIER JA, BIEDERMAN J, TOHEN M et al.: A prospective open-label treatment trial of olanzapine monotherapy in children and adolescents with bipolar disorder. J. Child Adolesc. Psychopharmacol. (2001) 11(3):239-250.
79. BIEDERMAN J, MICK E, HAMMERNESS P et al.: Open-label, 8-week trial of olanzepine and risperidone for the treatment of bipolar disorder in preschool-age children. Biol. Psychiatry (2005) 58(7):589-594.
80. TOHEN M, KRYZHANOVSKAYA L, CARLSON G et al.: Olanzapine in the treatment of acute mania in adolescents with bipolar I disorder: a 3-week randomized double-blind placebo-controlled study. 44th Annual Meeting of the American College of Neuropsychopharmacology. Kohala, HI (13 December 2005) (2005).
81. FRAZIER JA, MEYER MC, BIEDERMAN J et al.: Risperidone treatment for juvenile bipolar disorder. a retrospective chart review. J. Am. Acad. Child Adolesc. Psychiatry (1999) 38(8):960-965.
82. BIEDERMAN J, MICK E, WOZNIAK J et al.: An open-label trial of risperidone in children and adolescents with bipolar disorder. J. Clin. Adolesc. Psychiatry (2005) 15(2):311-317.
83. MASI G, MUCCI M, MILLEPIEDI S: Clozapine in adolescent inpatients with acute mania. J. Child Adolesc. Psychopharmacol. (2002) 12(2):93-99.
84. SCHULTE PF: Risk of clozapine-associated agranulocytosis and mandatory white blood cell monitoring. Ann. Pharmacother. (2006) 40(4):683-688.
85. KILLIAN JG, KERR K, LAWRENCE C et al.: Myocarditis and cardiornyopathy associated with clozapine. Lancet (1999) 354(9193):1841-1845.
86. BARNETT MS: Ziprasidone monotherapy in pediatric bipolar disorder. J. Child Adolesc. Psychopharmacol. (2004) 14(3):471-477.
87. BIEDERMAN J, MCDONNELL MA, WOZNIAK J et al.: Aripiprazole in the treatment of pediatric bipolar disorder: a systematic chart review. CNS Spectr. (2005) 10(2):141-148.
88. CORRELL CU, CARLSON HE: Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. J. Am. Acad. Child Adolesc. Psychiatry (2006) 45(7):771-791.
89. YUMRU M, SAVAS HA, KURT E et al.: Atypical antipsychotics related metabolic syndrome in bipolar patients. J. Affect. Disord. (2006) 98(3):247-252.
90. AMERICAN DIABETES ASSOCIATION: American psychiatric association. Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care (2004) 27(2):596-601.
91. FRISTAD MA, GOLDBERG-ARNOLD JS, GAVAZZI SM: Multifamily psychoeducation groups (MFPG) for families of children with bipolar disorder. Bipolar Disord. (2002) 4:254-262.
92. PAVULURI MN, GRACZYK PA, HENRY DB, CARBRAY JA, HEIDENREICH J, MIKLOWITZ DJ: Child and family-focused cognitive-behavioral therapy for pediatric bipolar disorder: development and preliminary results. J. Am. Acad. Child Adolesc. Psychiatry (2004) 43:528-537.
93. MIKLOWITZ DJ, GEORGE EL, AXELSON DA et al.: Family-focused treatment for adolescents with bipolar disorder. J. Affect. Disord. (2004) 82(Suppl 1):S113-S128.
94. KAPLAN BJ, FISHER JE, CRAWFORD SG, FIELD CJ, KOLB B: Improved mood and behavior during treatment with a mineral-vitamin supplement: an open-label case series of children. J. Child Adolesc. Psychopharmacol. (2004) 14(1):115-122.
95. KAPLAN BJ, SIMPSON JS, FERRE RC, GORMAN CP, MCMULLEN DM, CRAWFORD SG: Effective mood stabilization in bipolar disorder with a chelated mineral supplement. J. Clin. Psychiatry (2001) 62:936-944.
96. GHAZIUDDIN N, KUTCHER SP, KNAPP P et al.: Practice parameter for use of electroconvulsive therapy with adolescents. J. Am. Acad. Child Adolesc. Psychiatry (2004) 43(12):1521-1539.
97. KAMPANI S, PAVULURI MN: Integrating pharmacotherapy and psychotherapy for paediatric bipolar disorder: translating science to service. J. Indian Assoc. Child Adolesc. Mental Health (2005) 1(2):2.
98. KOWATCH RA, FRISTAD M, BIRMAHER B, WAGNER KD, FINDLING RL, HELLANDER M: Child psychiatric workgroup on bipolar disorder: treatment guidelines for children and adolescents with bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry (2005) 44(3):213-235.
99. PATEL NC, DELBELLO MP, BRYAN HS et al.: Open-label lithium for the treatment of adolescents with bipolar depression. J. Am. Acad. Child Adolesc. Psychiatry (2006) 45(3):289-297.
100. DANDO TM, KEATING GM: Spotlight on quetiapine in acute mania and depression associated with bipolar disorder. CNS Drugs (2006) 20(5):429-431.
101. BIEDERMAN J, MICK E, SPENCER TJ, WILENS TE, FARAONE SW: Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young. J. Child Adolesc. Psychopharmacol. (2000) 10:185-192.
102. BAUMER FM, HOWE M, GALLELLI K, SIMEONOVA DI, HALLMAYER J, CHANG KD: A pilot study of antidepressant-induced mania in pediatric bipolar disorder, charactetistics, risk factors, and the serotonin transporter gene. Biol. Psychiatry (2006) 60(9):1005-1012.
103. KAFANTARIS V, COLETTI DJ, DICKER R, PADULA G, KANE JM: Adjunctive antipsychotic treatment of adolescents with bipolar psychosis. J. Am. Acad. Child Adolesc. Psychiatry (2001) 40(12):1448-1456.
104. PAVULURI MN, HENRY DB, CARBRAY JA et al.: Open-label prospective trial of risperidone in combination with lithium or divalproex sodium in pediatric mania. J. Affect. Disord. (2004) 82(Suppl. 1):S103-S111.
105. GALANTER CA, CARLSON GA, JENSEN PS et al.: Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial. J. Child Adolesc. Psychopharmacol. (2003) 13(2):123-136.
106. GAO K, MUZINA D, GAJWANI P, CALABRESE JR: Efficacy of typical and atypical antipsychotics for primary and comorbid anxiety symptoms or disorders: a review. J. Clin. Psychiatry (2006) 67(9):1327-1340.
107. FINDLING RL, MCNAMARA NK, YOUNGSTROM EA et al.: Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J. Am. Acad. Child Adolesc. Psychiatry (2005) 44(5):409-417.
108. FINDLING RL, MCNAMARA NK, STANSBREY R et al.: Combination lithium and divalproex sodium in pediatric bipolar symptom re-stabilization. J. Am. Acad. Child Adolesc. Psychiatry (2006) 45(2):142-148.